Pharmacotherapy for SARS-CoV-2 and Seizures for drug repurposing presumed on Mechanistic Targets
CONCLUSION: These findings would hopefully provide the basis for initiating further studies on the pathogenesis and drug targeting strategies for this emerging infection accompanied with seizures or in people with epilepsy.PMID:34645381 | DOI:10.2174/1874467214666211013122528
Source: Epilepsy Curr - Category: Neurology Authors: Divya Goel Ankit Srivastava Ángel Aledo-Serrano Anuja Krishnan Divya Vohora Source Type: research
More News: Actemra | Brain | Coronavirus | COVID-19 | Databases & Libraries | Dexamethasone | Epidemiology | Epilepsy | Headache | Migraine | Neurology | Pneumonia | SARS | Stroke | Study | Toxicology